FDA Investigator Stephen J Koniers
Stephen J Koniers has inspections in 10 countries as of 29 Sep 2023. Stephen J Koniers has collaborated with a combinined 2839 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
25
Last Inspection Date:
29 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Japan,
United States of America,
Germany,
India,
China,
Hungary,
Italy,
Austria,
United Kingdom of Great Britain and Northern Ireland,
Israel
Co-Investigator(s):
Addam S Reynolds,
Adetutu M Gidado,
Amy L Singer,
Amy M Cramer,
Anastasia I Offordile,
Anastasia M Shields,
Anita R Michael,
Ankur C Patel,
Anthony A Charity,
Arthur T Ogdahl,
Atul J Agrawal,
Audrey Thereset Uy,
Azza Talaat,
Barbara Jwilimczyk Macri,
Bijoy Panicker,
Bonita S Chester,
Brandon C Heitmeier,
Brandy N Lepage,
CDR Rochelle B Young, RPh, MSA,
Charisse K Green,
Charles M Edwards,
Christopher S Keating,
Colleen M Damon,
Craig D Zagata,
Cynthia A Palmer,
Daniel J Grabicki,
Dawn E Barkans,
Dawn L Wydner,
Debra J Bennett,
Debra L Pagano,
Denise M Digiulio,
Dennis Cantellops Paite,
Dorothy J Denes,
Dr. Barbara D Paul, PhD,
Dr. Carmelo Rosa,
Eileen A Liu,
Erika E Englund, PhD,
Erika V Butler,
Felix Maldonado,
Frederick Razzaghi,
Gayle S Lawson,
George Pyramides,
Hala L Selby,
Hala Lj Whetstone,
Helen Verdel,
Heriberto Negron Rivera,
Israel Santiago, OCM,
Ivis Lnegron Torres,
Jaison J Eapen,
James C Illuminati,
James M Mason,
James R Birkenstamm,
Jean Blackston Hill,
Jean Blackstone Hill,
Jennifer J Stone,
Jennifer L Huntington,
Joanne Heim,
Joanne M Hajoway,
John D White,
Jose Acruz Gonzalez,
Jose Alopez Rubet,
Jose M Cayuela,
Jose R Hernandez,
Julianne C Mccullough,
Jullianne C Mccullough,
Junho Pak,
Junho Park,
Kara D Dobbin,
Karen A Briggs,
Karen E D'orazio,
Karyn M Campbell,
Katherine Szestypalow,
Kelli F Dobilas,
Kendra L Brooks,
Kenneth M Gordon,
Kham Phommachanh,
Ko U Min,
Kristen D Evans,
Kristina J Donohue,
Kristina Mjoyce Pittman,
Kristy A Zielny,
Lance M De Souza, MBA,
Larry K Austin,
Lauren N Barber,
Leonard H Lavi,
Linda M Hoover,
Lisa B Orr,
Lisa M Bellows,
Luella J Rossi,
Luis A Dasta,
Marea K Harmon,
Margaret M Annes,
Marie F Morin,
Mary E Storch,
Matthew B Casale,
Matthew R Noonan,
Meena Bansal Gupta, PhD,
Megan A Haggerty,
Melissa J Garcia,
Michael A Charles,
Michael A Taylor,
Michael Gurbarg,
Michael J Kuchta,
Michael L Casner,
Michael L Chasey,
Michael R Klapal,
Michael Serrano,
Michele Gottshall,
Michele L Glendenning,
Michele L Obert,
Michele M Falchek,
Miguel A Martinez,
Mihaly S Ligmond,
Monica M Mcclure,
Monika Borkowska,
Mra Mcculloughj,
Mra Munizn,
Nancy M Espinal,
Nicholas A Violand,
Noreen Muniz,
Parul M Patel,
Patrick C Klotzbuecher,
Patrick L Wisor,
Patsy J Domingo,
Paul A Bonneau,
Paul L Bellamy,
Rabin N Ghoshal,
Randy L Self,
Raquel Gonzalez Rivera,
Regina T Brown,
Richard E Needham,
Robert B Shibuya, MD,
Robert J Maffei,
Robert M Barbosa,
Roger F Zabinski,
Rose Ljean Mary,
Russell J Glapion,
Russell K Riley,
Saleem A Akhtar,
Sam Pepe,
Santos E Camara,
Satheesh Thomas,
Sharon K Thoma, PharmD,
Shirley J Berryman,
Stephanie Mangigian, MS/OSH, RN,
Steven M Weinman,
Susan F Laska, MS,
Tamil Arasu, PhD,
Tammy L Chavis,
Temar Q Williams,
Thomas E Friel,
Tiffani D Wilson,
Torrance J Slayton,
Vlada Matusovsky,
Yumi J Hiramine,
Yvesna C Blaise,
Zachary A Bogorad
Stephen J Koniers's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| September, 2012 | FDA 483 | Aurobindo Pharma Limited - Form 483, 2012-09-21 |
| August, 2002 | FDA 483 | Microbac Labs Inc - Form 483, 2002-08-29 |
| September, 2012 | FDA 483 | Hikal Limited - Form 483, 2012-09-13 |
| January, 2012 | FDA 483 | Frontida BioPharm, LLC - Form 483, 2012-01-27 |
| September, 2013 | FDA 483 | Purdy-Pak, Inc. dba Tite-Pak & PPI - Form 483, 2013-09-11 |
| December, 2013 | EIR | KVK-TECH, INC. - EIR, 2013-12-09 |
| December, 2013 | FDA 483 | KVK-TECH, INC. - Form 483, 2013-12-09 |
| July, 2006 | EIR | PEL HEALTHCARE LLC - EIR, 2006-07-19 |
| January, 2011 | FDA 483 | PETNET SOLUTIONS, INC. - Form 483, 2011-01-31 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more